Literature DB >> 23532506

Does melatonin affect epileptic seizures?

Siddharth Jain1, Frank M C Besag.   

Abstract

Melatonin is widely used for sleep disorders in patients with a range of developmental disorders and neurodisabilities, who also frequently have epilepsy. The aim of our review was to examine published data to assess the evidence for melatonin affecting seizure control. The literature search revealed 26 papers apparently reporting an association between melatonin and epilepsy or seizures but seven of these did not provide relevant information. Of the three double-blind, randomised, controlled trials, two showed no overall worsening or improvement in seizures, and one recent trial reported a statistically significant reduction in seizures. The open studies reported conflicting results. The few studies on the effect of seizures on melatonin levels have reported that baseline melatonin levels may be low in patients with uncontrolled epilepsy and that levels increase markedly following seizures. The striking finding of this review is the paucity of relevant data from the remarkably small number of studies. These results allow no firm conclusions to be drawn, although it would seem reasonable to observe that there was no marked overall effect on seizures, neither improvement nor worsening. There is a need for large, well designed, randomised, double-blind, placebo-controlled trials to establish the role of melatonin in either predisposing to or decreasing the likelihood of seizures.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23532506     DOI: 10.1007/s40264-013-0033-y

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  30 in total

Review 1.  Endogenous melatonin and epileptogenesis: facts and hypothesis.

Authors:  L S Stewart
Journal:  Int J Neurosci       Date:  2001-03       Impact factor: 2.292

2.  [Effect of melatonin on intractable epilepsies].

Authors:  Judit Saracz; Beáta Rosdy
Journal:  Orv Hetil       Date:  2004-12-19       Impact factor: 0.540

3.  Pro-convulsant effects of oral melatonin in neurologically disabled children.

Authors:  S H Sheldon
Journal:  Lancet       Date:  1998-04-25       Impact factor: 79.321

4.  Add-on melatonin improves sleep behavior in children with epilepsy: randomized, double-blind, placebo-controlled trial.

Authors:  Madhur Gupta; Satinder Aneja; Kamlesh Kohli
Journal:  J Child Neurol       Date:  2005-02       Impact factor: 1.987

5.  Melatonin administration after pilocarpine-induced status epilepticus: a new way to prevent or attenuate postlesion epilepsy?

Authors:  Eliângela Lima; Francisco R Cabral; Esper A Cavalheiro; Maria da Graça Naffah-Mazzacoratti; Débora Amado
Journal:  Epilepsy Behav       Date:  2011-03-30       Impact factor: 2.937

Review 6.  [Melatonin and epilepsy].

Authors:  M Rufo-Campos
Journal:  Rev Neurol       Date:  2002-09       Impact factor: 0.870

7.  Patients with intractable epilepsy have low melatonin, which increases following seizures.

Authors:  C W Bazil; D Short; D Crispin; W Zheng
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

Review 8.  Melatonin's role as an anticonvulsant and neuronal protector: experimental and clinical evidence.

Authors:  A Muñoz-Hoyos; M Sánchez-Forte; A Molina-Carballo; G Escames; E Martin-Medina; R J Reiter; J A Molina-Font; D Acuña-Castroviejo
Journal:  J Child Neurol       Date:  1998-10       Impact factor: 1.987

9.  The Chalfont Seizure Severity Scale.

Authors:  J S Duncan; J W Sander
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-10       Impact factor: 10.154

10.  Melatonin response in active epilepsy.

Authors:  G J Schapel; R G Beran; D L Kennaway; J McLoughney; C D Matthews
Journal:  Epilepsia       Date:  1995-01       Impact factor: 5.864

View more
  9 in total

1.  Melatonin improves sleep in children with epilepsy: a randomized, double-blind, crossover study.

Authors:  Sejal V Jain; Paul S Horn; Narong Simakajornboon; Dean W Beebe; Katherine Holland; Anna W Byars; Tracy A Glauser
Journal:  Sleep Med       Date:  2015-01-21       Impact factor: 3.492

Review 2.  Adverse Events Associated with Melatonin for the Treatment of Primary or Secondary Sleep Disorders: A Systematic Review.

Authors:  Frank M C Besag; Michael J Vasey; Kim S J Lao; Ian C K Wong
Journal:  CNS Drugs       Date:  2019-12       Impact factor: 5.749

3.  Melatonin supplementation for the treatment of infantile spasms: protocol for a randomised placebo-controlled triple-blind trial.

Authors:  Yulin Sun; Weiwei Feng; Jian Chen; Miao Liu; Xiuyu Shi; Jing Wang; Liping Zou; Tao Xu; Guang Yang
Journal:  BMJ Open       Date:  2022-07-04       Impact factor: 3.006

Review 4.  Sleep, Circadian Rhythms, and Epilepsy.

Authors:  Joseph T Daley; Jennifer L DeWolfe
Journal:  Curr Treat Options Neurol       Date:  2018-09-27       Impact factor: 3.598

Review 5.  Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs.

Authors:  Dubravka Svob Strac; Nela Pivac; Ilse J Smolders; Wieslawa A Fogel; Philippe De Deurwaerdere; Giuseppe Di Giovanni
Journal:  Front Neurosci       Date:  2016-11-10       Impact factor: 4.677

Review 6.  Epilepsy in patients with autism: links, risks and treatment challenges.

Authors:  Frank Mc Besag
Journal:  Neuropsychiatr Dis Treat       Date:  2017-12-18       Impact factor: 2.570

Review 7.  The Mutual Interaction Between Sleep and Epilepsy on the Neurobiological Basis and Therapy.

Authors:  Yi-Qun Wang; Meng-Qi Zhang; Rui Li; Wei-Min Qu; Zhi-Li Huang
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

Review 8.  Pediatric sleep disturbances and treatment with melatonin.

Authors:  Susanna Esposito; Daniela Laino; Renato D'Alonzo; Annalisa Mencarelli; Lorenza Di Genova; Antonella Fattorusso; Alberto Argentiero; Elisabetta Mencaroni
Journal:  J Transl Med       Date:  2019-03-12       Impact factor: 5.531

9.  GIRK Channels Mediate the Nonphotic Effects of Exogenous Melatonin.

Authors:  Lauren M Hablitz; Hylton E Molzof; Kathryn E Abrahamsson; Joanna M Cooper; Rebecca A Prosser; Karen L Gamble
Journal:  J Neurosci       Date:  2015-11-11       Impact factor: 6.167

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.